Actorif (Interferon β -1a) / Actoverco, AMEGA Biotech - LARVOL DELTA

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS (clinicaltrials.gov) - P4, N=345;

Multiple Sclerosis

Magnetic resonance imaging results from a phase III, randomized, double-blind, placebo-controlled, multicenter trial of two dosing frequencies of subcutaneous interferon beta-1a in patients with clinically isolated syndrome (REFLEX) (AAN 2011) - P3, REFLEX STUDY; N=517; Both dosing frequencies of sc IFN beta-1a significantly improved MRI outcomes reflecting disease activity in patients with CIS compared with placebo, with more pronounced effects in the higher frequency treatment arm

P3 data • Multiple Sclerosis

Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate (Eur Neurol) - Abstract not available

Multiple Sclerosis